AFG
ABBV icon

Allegheny Financial Group’s AbbVie ABBV Stock Holding History

Allegheny Financial Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.2M Buy
8,745
+30
+0.3% +$6.45K 0.23% 65
2026
Q1 		$1.9M Sell
8,715
-142
-2% -$31.5K 0.26% 69
2025
Q4 		$2.02M Sell
8,857
-190
-2% -$43.3K 0.3% 61
2025
Q3 		$2.09M Sell
9,047
-301
-3% -$61.3K 0.39% 50
2025
Q2 		$1.74M Buy
9,348
+25
+0.3% +$4.65K 0.39% 55
2025
Q1 		$1.95M Sell
9,323
-149
-2% -$29K 0.5% 36
2024
Q4 		$1.68M Sell
9,472
-84
-0.9% -$15.4K 0.43% 48
2024
Q3 		$1.89M Buy
9,556
+94
+1% +$17.5K 0.47% 36
2024
Q2 		$1.62M Buy
9,462
+1,894
+25% +$314K 0.47% 37
2024
Q1 		$1.38M Buy
7,568
+50
+0.7% +$8.62K 0.43% 40
2023
Q4 		$1.17M Buy
7,518
+158
+2% +$23K 0.37% 48
2023
Q3 		$1.1M Buy
7,360
+3,314
+82% +$487K 0.41% 44
2023
Q2 		$545K Sell
4,046
-3,374
-45% -$495K 0.26% 78
2023
Q1 		$1.18M Sell
7,420
-414
-5% -$63.3K 0.48% 39
2022
Q4 		$1.27M Sell
7,834
-197
-2% -$30.2K 0.53% 35
2022
Q3 		$1.08M Sell
8,031
-177
-2% -$25.4K 0.51% 37
2022
Q2 		$1.26M Sell
8,208
-66
-0.8% -$10.1K 0.59% 35
2022
Q1 		$1.34M Sell
8,274
-270
-3% -$39.2K 0.57% 35
2021
Q4 		$1.16M Buy
8,544
+1
+0% +$118 0.46% 40
2021
Q3 		$922K Buy
8,543
+39
+0.5% +$4.46K 0.42% 45
2021
Q2 		$958K Sell
8,504
-349
-4% -$39.3K 0.43% 43
2021
Q1 		$958K Buy
8,853
+33
+0.4% +$3.53K 0.7% 26
2020
Q4 		$945K Buy
+8,820
New +$848K 0.51% 35

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Allegheny Financial Group's ABBV Position: Q2 2026 in Review

Allegheny Financial Group increased its AbbVie (ABBV) stake by 0.34% in Q2 2026, buying an estimated $6.45K and bringing the position to 8,745 shares worth $2.2M. The position accounts for 0.23% of the portfolio, ranked #65.

Allegheny Financial Group first reported a position in ABBV in Q4 2020 and has held it in 23 quarters since. 4,209 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Allegheny Financial Group held 8,745 shares of AbbVie worth $2.2M as of Q2 2026.
  • Allegheny Financial Group bought 30 AbbVie shares in Q2 2026, an estimated $6.45K.
  • AbbVie made up 0.23% of Allegheny Financial Group's portfolio in Q2 2026, its #65 holding.
  • Allegheny Financial Group first reported a position in AbbVie in Q4 2020 and has held it in 23 quarters since.
  • 4,209 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Allegheny Financial Group's 13F filing for Q2 2026, filed 22 Jul 2026.